To evaluate the ADCC activity of expanded NK cells, a CD107a degranulation assay was performed using HER2-positive tumor cell lines, including the breast cancer cell lines BT-474 and SKBR-3, and the gastric cancer cell line NCI-N87. This evidence concerns the gene ERBB2 and breast carcinoma.